Strax

Autospela

The future of CTCL therapy

4 Visningar • 08/09/23
Dela med sig
Bädda in
administrator
administrator
Prenumeranter
0

Martine Bagot, MD, PhD, Hôpital Saint Louis, Paris, France, suggests how the therapeutic landscape of cutaneous T-cell lymphoma (CTCL) may evolve in the future, with the development of novel monoclonal antibodies, oncogenic peptides, and agents targeting overactivated signaling pathways in CTCL. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

Visa mer
0 Kommentarer sort Sortera efter
Facebook-kommentarer

Strax

Autospela